We are live on ! Find out more
NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

10 hedge funds and large institutions have $11.5M invested in NewAmsterdam Pharma Warrant in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.3% less ownership

Funds ownership: 1.74% → 1.45% (-0.3%)

9% less funds holding

Funds holding: 11 → 10 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

94% less capital inflows, than outflows

Capital inflows: $93.3K | Capital outflows: $1.68M

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
$654K
Puts
–
Net Calls
+$654K
Net Calls Change
-$174K

Top Buyers

Rank Fund Capital Flow
1
TFC Financial Management
TFC Financial Management
Massachusetts
+$93.3K

Top Sellers

Rank Fund Capital Flow
1
GTS Securities
GTS Securities
Florida
-$1.34M
2
Monashee Investment Management
Monashee Investment Management
Massachusetts
-$344K

NAMSW Hedge Fund Activity: Q2 2024 in Review

10 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q2 2024, worth a combined $11.5M — down 28% from $15.9M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NAMSW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was TFC Financial Management, opening a new position worth an estimated $93.3K. The largest seller was GTS Securities, exiting entirely with an estimated $1.34M sold.

  • 10 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q2 2024, down from 11 in Q1 2024.
  • Funds reported $11.5M of NewAmsterdam Pharma Warrant stock for Q2 2024, down 28% quarter-over-quarter.
  • 1 fund opened new NewAmsterdam Pharma Warrant positions in Q2 2024 and 2 closed out, a net change of -1 holder.
  • The largest NewAmsterdam Pharma Warrant buyer in Q2 2024 was TFC Financial Management, an estimated $93.3K added.
  • The largest NewAmsterdam Pharma Warrant seller in Q2 2024 was GTS Securities, an estimated $1.34M sold.

Based on aggregated 13F filings for Q2 2024.